AIDS Treatment Data Network
611 Broadway, Suite 613, New York, NY, 10012 • www.atdn.org • Tel: (212) 260-8868 • (NYS) 800-734-7104
The Access Project collects and distributes information about medications available for HIV/AIDS and hepatitis co-infection through Medicaid, Medicare Part D, AIDS Drug Assistance Programs (ADAPs), and pharmaceutical industry sponsored patient assistance and expanded access programs (EAP). The Access Project is a program of the The Network (network@atdn.org)

Janssen Pharmaceuticals
Patient Assistance Program

Products covered:

Duragesic (fentanyl transdermal)
Nizoral (ketoconazole)
Sporonox (itraconazole) 1-800-652-6227



Contact
Program Eligibility
The patient must meet the following criteria to qualify:
  • Has no health insurance or no prescription coverage.
  • Not eligible for Medicaid, ADAP, Medicare Part D, or other drug assistance programs.
  • Financial eligibility is evaluated on a case-by-case basis.
Enrollment Process
Doctors and patients can call to enroll. An application is sent to the doctor's office for completion by both.
Re-Application
Once accepted into the program, a re-evaluation form will be sent to the doctor's office. This will have to be completed and sent back to the program in order to continue receiving drug.

About The Network - Donate - About The Access Project
Last modified: 11/16/2007
© 2007 The Network